Ingevity Corp (NGVT)

↓ Download CSV

CIK 0001653477 · NYSE · Chemicals & Allied Products

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Ingevity Corp reported revenue of $1.17B, down 2.7% from the prior year. The company ran a net loss, with a net margin of -14.3% and a gross margin of 39.5%. It held $1.65B in total assets against $1.62B in total liabilities.

Key ratios (FY2025)

39.5%
Gross margin
35.9%
Operating margin
-14.3%
Net margin
-562.6%
Return on equity
-2.7%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$1.17B$1.20B$1.22B$1.67B$1.39B$1.22B$1.29B$1.13B$972.40M$908.30M
Cost of Revenue$706.10M$735.30M$770.50M$1.10B$878.70M$750.60M$810.90M$716.80M$643.40M$633.90M
Gross Profit$461.50M$464.80M$445.00M$570.10M$512.80M$465.50M$482.00M$416.80M$329.00M$274.40M
Operating Income$418.70M$425.90M$423.20M$452.60M$422.20M$397.90M$396.90M$320.50M$242.70M$163.60M
Net Income-$167.10M-$430.30M-$5.40M$211.60M$118.10M$181.40M$183.70M$169.10M$126.50M$35.20M
EPS (Diluted)$-4.61$-11.85$-0.15$5.50$2.95$4.37$4.35$3.97$2.97$0.83
Total Assets$1.65B$2.02B$2.62B$2.74B$2.47B$2.33B$2.14B$1.32B$929.60M$832.80M
Total Liabilities$1.62B$1.83B$1.99B$2.04B$1.80B$1.69B$1.61B$976.50M$651.70M$698.20M
Shareholders' Equity$29.70M$195.20M$631.40M$698.30M$673.80M$642.10M$338.70M$263.90M$127.00M
Cash & Equivalents$78.10M$68.00M$95.90M$76.70M$275.40M$257.70M$56.50M$77.50M$87.90M$30.50M
Operating Cash Flow$331.20M$128.60M$205.10M$313.40M$293.30M$352.40M$275.70M$252.00M$174.30M$127.90M
Capital Expenditures$57.70M$77.60M$109.80M$142.50M$103.80M$82.10M$114.80M$93.90M$52.60M$56.70M
Shares Outstanding36.22M36.32M36.71M38.47M40.06M41.55M42.20M42.60M42.53M42.27M